Emergence of MPLW515 mutation in a patient with CALR deletion: Evidence of secondary acquisition of MPL mutation in the CALR clone

Hematol Oncol. 2018 Feb;36(1):336-339. doi: 10.1002/hon.2431. Epub 2017 May 29.

Abstract

Myeloproliferative neoplasms are characterized by transduction pathway recognized as mutually exclusive molecular abnormalities such as BCR-ABL translocation, JAK2V617F or JAK2 exon 12 mutations, MPL w515, and CALR mutations. However, in some rare cases, associations of such mutations are found in 1 patient. This can be related to 2 pathologies (at least 2 different clones harboring 2 mutations) or associated mutations in 1 clone. We describe here such an association of CALR and MPL mutations in a patient harboring the second mutation in a subclone during the phenotypic evolution of the myeloproliferative neoplasms.

Keywords: CALR; MPL; MPN; essential thrombocythemia; myelofibrosis.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Mutation
  • Myeloproliferative Disorders / genetics*
  • Myeloproliferative Disorders / pathology
  • Sequence Deletion
  • Thrombocythemia, Essential / genetics*
  • Thrombocythemia, Essential / pathology
  • Young Adult